Curevac announces update to the management team

TÜbingen, germany and boston, ma / accesswire / july 14, 2023 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced that dr. igor splawski, curevac's chief scientific officer, will step down effective july 14, 2023 to return to early-stage research in the united states.
CVAC Ratings Summary
CVAC Quant Ranking